Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.

Danuta M Skowronski,Erica Sy Chuang,Suzana Sabaiduc, Samantha E Kaweski,Shinhye Kim,James A Dickinson,Romy Olsha,Jonathan B Gubbay,Nathan Zelyas,Hugues Charest,Nathalie Bastien,Agatha N Jassem,Gaston De Serres

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin（2023）

引用 11|浏览27

暂无评分

摘要

The Canadian Sentinel Practitioner Surveillance Network estimated vaccine effectiveness (VE) during the unusually early 2022/23 influenza A(H3N2) epidemic. Like vaccine, circulating viruses were clade 3C.2a1b.2a.2, but with genetic diversity affecting haemagglutinin positions 135 and 156, and reassortment such that H156 viruses acquired neuraminidase from clade 3C.2a1b.1a. Vaccine provided substantial protection with A(H3N2) VE of 54% (95% CI: 38 to 66) overall. VE was similar against H156 and vaccine-like S156 viruses, but with potential variation based on diversity at position 135.

查看译文

关键词

A(H3N2),Influenza,clade,imprinting,observational study,reassortment,test-negative design,vaccine effectiveness

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要